OTC : EKTAF
$0 (0.0%)
OTC
Jakob Just-Bomholt
Medical - Instruments & Supplies
Healthcare
EKTAF
4541
SE
USD
1.03
0.87
0.68
0.21
-1.77
$16.61B
1.02
2.51
8.14
5.47
-$1.38
-$516.57M
-3.10%
-0.81%
-6.37%
-1.93%
-34.36
-0.39
-0.39
2/5
0 Analysts
%
1.44
4/9
-$1.95B
$26.78B
$19.68B
$504.95M
$21.25B
1.27
12.16
0.87
-6.37%
5.87%
-2.90%
12.26%
188 days
| Name | Title |
|---|---|
| Kathy Pajari | Head of Corporate Communications |
| Christina Raaschou | Chief Human Resources Officer |
| Christopher Busch | Chief Product & Technology Officer |
| Laurent Leksell | Founder & Chairman |
| Hilma Nordquist | Global Sustainability Director |
| Jakob Just-Bomholt | Chief Executive Officer & President |
| John Lapré | Chief Business Line Officer |
| Jonas Bolander | Chief Legal Officer |
| Mattias Thorsson | Vice President and Head of Corporate Communications & Public Affairs |
| Peter Nyquist | Head of Investor Relations |
| Caroline Leksell Cooke | Senior Vice President & Head of Neuro Solutions |
| Klara Eiritz | Chief Financial Officer |
No votes yet today — be the first to share your view!
About Elekta AB (publ) (OTC:EKTAF) Stock
Elekta AB (publ) is a global medical technology enterprise providing advanced clinical tools for the treatment of cancer and neurological conditions. Their extensive product portfolio includes leading solutions for radiotherapy, such as Versa HD for brain metastases, the innovative Elekta Unity MR-Linac, Elekta Harmony linear accelerator, and systems like Elekta Infinity and Elekta Synergy for diverse radiotherapy needs, including advanced image guidance. They also offer comprehensive treatment management, quality assurance, and motion management technologies. For multidisciplinary cancer care, Elekta provides MOSAIQ Plaza and the Elekta Axis Cloud managed hosting service. In brachytherapy, their offerings range from the image-guided Elekta Studio and mobile CT ImagingRing to specialized a ... pplicators like Venezia and Geneva for cervical cancer, supported by the Oncentra Brachy smart tool and Flexitron afterloader. Their renowned Leksell Gamma Knife series – Icon, Perfexion, and Lightning – delivers precise and accelerated radiosurgery for various indications. Additionally, Elekta supplies neurosurgery products, including the Leksell Vantage and Leksell Stereotactic Systems for both intracranial and minimally invasive procedures. Established in 1972, the company maintains its headquarters in Stockholm, Sweden.
Elekta AB (publ) (EKTAY) Q4 2026 Earnings Call Transcript
2026-05-28 08:14:29
Elekta AB (publ) (EKTAY) Q4 2026 Earnings Call Transcript
Frequently Asked Questions
What is the current Elekta AB (publ) (EKTAF) stock price?
Elekta AB (publ)(OTC:EKTAF) stock price is $5.25 in the last trading session. During the trading session, EKTAF stock reached the peak price of $6.83 while $4.48 was the lowest point it dropped to. The percentage change in EKTAF stock occurred in the recent session was 0.0% while the dollar amount for the price change in EKTAF stock was $0.
EKTAF's industry and sector of operation?
The OTC listed EKTAF is part of Medical - Instruments & Supplies industry that operates in the broader Healthcare sector.
Who are the executives of EKTAF?
Kathy Pajari
| Head of Corporate Communications
Christina Raaschou
| Chief Human Resources Officer
Christopher Busch
| Chief Product & Technology Officer
Laurent Leksell
| Founder & Chairman
Hilma Nordquist
| Global Sustainability Director
How many employees does EKTAF have?
Number of EKTAF employees currently stands at 4541. EKTAF operates from Hagaplan 4, Stockholm, SD 103 93, SE.
Link for EKTAF official website?
Official Website of EKTAF is: https://www.elekta.com
How do I contact EKTAF?
EKTAF could be contacted at phone #46 8 58 72 54 00 and can also be accessed through its website. EKTAF operates from Hagaplan 4, Stockholm, SD 103 93, SE.
How many shares of EKTAF are traded daily?
The average number of EKTAF shares traded daily for last 3 months was 170.
What is the market cap of EKTAF currently?
The market value of EKTAF currently stands at $1.93B with its latest stock price at $5.25